Delivery Order SPE2DB22D3019-SPE2DB25FK2YS
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.74 fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,417.25 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with an ultimate completion date of December 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, is for the delivery of Bromfenac Sodium 0.09% Eye Drops 1.7ML. The $1,575.92 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 5, 2024.
The contract is not designated as a set-aside award. AmerisourceBergen, a for-profit organization, holds a significant $999,999,999 Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the provision of Bromfenac Sodium 0.09% Eye Drops in 1.7ml containers, with a total ceiling value of $1,131.37 and a period of performance through March 12, 2024.
The award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,695.47 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a completion date of November 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $4,236.38 firm fixed-price contract is for the supply of 4565951611 - Bromfenac Sodium 0.09% Eye Drops in 1.7 milliliter containers. The contract has an ultimate completion date of September 27, 2024. Amerisourcebergen Drug Corp is a for-profit organization and holds significant Indefinite Delivery Contracts (IDCs) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Bromfenac Sodium 0.07% Eye Drops, 3mL. The contract has a ceiling value of $1,059.39 and a completion date of August 1, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription medication, with a ceiling value of $1,543.80 and a completion date of October 30, 2024. This appears to be a Firm Fixed Price delivery order contract, which is not designated as a set-aside.
AmerisourceBergen holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Bromfenac Sodium 0.09% eye drops. This $1,488.72 contract has a performance period through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,846.68 firm fixed-price delivery order is for the supply of Bromfenac Sodium 0.09% eye drops, with a performance period ending on May 8, 2024. The contract is not designated with a set-aside requirement, indicating open competition.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...